PHASE 1 SAFETY AND TOLERABILITY STUDY OF IMB-1018972, A NOVEL ORAL MODULATOR OF MYOCARDIAL SUBSTRATE UTILIZATION DESIGNED TO IMPROVE CARDIAC METABOLIC EFFICIENCY AND BIOENERGETICS
Journal of the American College of Cardiology(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要